malondialdehyde has been researched along with ro13-9904 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Chaudhary, M; Dwivedi, VK; Soni, A | 1 |
Chaudhary, M; Dwivedi, VK; Kumar, S; Shrivastava, SM; Soni, A | 1 |
Abnous, K; Amin, B; Hajhashemi, V; Hosseinzadeh, H | 1 |
Çavuşoğlu, T; Erbas, O; Özkeşkek, K; Solmaz, V; Tümer, MK; Uyanikgil, Y | 1 |
Andrisic, L; Jarocka-Karpowicz, I; Moniuszko-Malinowska, A; Pancewicz, S; Skrzydlewska, E; Zajkowska, J; Zarkovic, N; Łuczaj, W | 1 |
Abdel-Daim, MM; Abushouk, AI; Al-Sultan, NK; Alahmari, A; Alarifi, S; AlBasher, G; Aleya, L; Alghamdi, J; Ali, D; Alkahtane, AA; Alkahtani, S; Almeer, RS; Bungau, SG; El-Bialy, BE | 1 |
Alver, A; Arslan, E; Biyik, MO; Bodur, A; Guvercin, AR; Kosucu, M | 1 |
7 other study(ies) available for malondialdehyde and ro13-9904
Article | Year |
---|---|
Ceftriaxone-vancomycin drug toxicity reduction by VRP 1020 in Mus musculus mice.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Catalase; Ceftriaxone; Drug Combinations; Kidney; Liver; Male; Malondialdehyde; Mice; Oxidative Stress; Superoxide Dismutase; Vancomycin | 2009 |
Evaluation of Vancoplus versus ceftriaxone against cephalosporin resistance MRSA strain in experimental meningitis model.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Cephalosporin Resistance; Malondialdehyde; Meningitis, Bacterial; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Models, Animal; Rats; Staphylococcal Infections; Vancomycin | 2010 |
Ceftriaxone, a beta-lactam antibiotic, modulates apoptosis pathways and oxidative stress in a rat model of neuropathic pain.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Apoptosis Regulatory Proteins; Ceftriaxone; Disease Models, Animal; Glutathione; Male; Malondialdehyde; Neuralgia; Oxidative Stress; Rats; Rats, Wistar; Time Factors | 2014 |
Positive effects of ceftriaxone on pentylenetetrazol-induced convulsion model in rats.
Topics: Animals; Anticonvulsants; Brain; Ceftriaxone; Convulsants; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrodes, Implanted; Electroencephalography; GABA Antagonists; Lipid Peroxidation; Male; Malondialdehyde; Myoclonus; Pentylenetetrazole; Random Allocation; Rats; Rats, Sprague-Dawley; Seizures; Superoxide Dismutase | 2016 |
Lipid peroxidation in the pathogenesis of neuroborreliosis.
Topics: Adult; Aged; Aged, 80 and over; Aldehydes; Borrelia burgdorferi; Ceftriaxone; Docosahexaenoic Acids; F2-Isoprostanes; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lyme Neuroborreliosis; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Phospholipases A2 | 2016 |
The ameliorative effects of ceftriaxone and vitamin E against cisplatin-induced nephrotoxicity.
Topics: Animals; Antioxidants; Catalase; Ceftriaxone; Cisplatin; Creatinine; Glutathione; Glutathione Peroxidase; Injections, Intraperitoneal; Kidney; Male; Malondialdehyde; Nitric Oxide; Rats; Superoxide Dismutase; Urea; Vitamin E | 2019 |
Is ceftriaxone effective in experimental brain ischemia/reperfusion injury?
Topics: Animals; Brain; Brain Ischemia; Ceftriaxone; Malondialdehyde; Neuroprotective Agents; Oxidative Stress; Rats; Reperfusion Injury | 2020 |